Cargando…
Targeted gene transfer into ependymal cells through intraventricular injection of AAV1 vector and long-term enzyme replacement via the CSF
Enzyme replacement via the cerebrospinal fluid (CSF) has been shown to ameliorate neurological symptoms in model animals with neuropathic metabolic disorders. Gene therapy via the CSF offers a means to achieve a long-term sustainable supply of therapeutic proteins within the central nervous system (...
Autores principales: | Yamazaki, Yoshiyuki, Hirai, Yukihiko, Miyake, Koichi, Shimada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076682/ https://www.ncbi.nlm.nih.gov/pubmed/24981028 http://dx.doi.org/10.1038/srep05506 |
Ejemplares similares
-
Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector
por: Hironaka, Kohei, et al.
Publicado: (2015) -
Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector
por: Nakamura-Takahashi, Aki, et al.
Publicado: (2016) -
Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model
por: Huda, Fathul, et al.
Publicado: (2014) -
Ependymal cells-CSF flow regulates stress-induced depression
por: Seo, Ji-Seon, et al.
Publicado: (2021) -
Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A
por: Miyake, Noriko, et al.
Publicado: (2021)